BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 83 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $25,000 | -56.9% | 19,104 | -65.6% | 0.00% | – |
| Q3 2019 | $58,000 | -37.0% | 55,535 | +2.7% | 0.00% | – |
| Q2 2019 | $92,000 | -96.2% | 54,087 | -92.5% | 0.00% | – |
| Q1 2019 | $2,441,000 | +20.7% | 724,315 | +4.6% | 0.00% | – |
| Q4 2018 | $2,022,000 | -52.9% | 692,408 | -0.6% | 0.00% | – |
| Q3 2018 | $4,291,000 | -10.3% | 696,443 | +7.5% | 0.00% | – |
| Q2 2018 | $4,782,000 | +61.8% | 647,709 | +43.8% | 0.00% | – |
| Q1 2018 | $2,956,000 | -19.9% | 450,332 | +2.8% | 0.00% | – |
| Q4 2017 | $3,689,000 | -25.8% | 438,277 | +1.8% | 0.00% | – |
| Q3 2017 | $4,971,000 | +2.0% | 430,457 | +3.2% | 0.00% | – |
| Q2 2017 | $4,872,000 | +10.3% | 416,966 | +16.6% | 0.00% | – |
| Q1 2017 | $4,416,000 | -0.6% | 357,645 | +9.7% | 0.00% | – |
| Q4 2016 | $4,442,000 | -28.2% | 326,037 | +4.9% | 0.00% | -100.0% |
| Q3 2016 | $6,188,000 | +68.2% | 310,895 | +9.5% | 0.00% | – |
| Q2 2016 | $3,678,000 | +250.0% | 283,795 | +152.5% | 0.00% | – |
| Q1 2016 | $1,051,000 | -49.0% | 112,395 | +10.5% | 0.00% | – |
| Q4 2015 | $2,062,000 | +86.4% | 101,723 | +113.3% | 0.00% | – |
| Q1 2015 | $1,106,000 | – | 47,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|